The Inflation Reduction Act, passed by Congress and signed into law by President Joe Biden in 2022, legislated new policies ...

Scientists have discovered that a promising new anticancer medicine currently in development could be made from unknown ...

Scientists from the University of the Philippines Diliman-College of Science conducted the first detailed microbial genomic study of an submarine groundwater discharge (SGD) site in the country, in ...

First-generation GLP-1 weight-loss drugs can help reduce the risk of obesity-related cancers, new research shows. Liraglutide ...

The global generic oncology drugs market size is estimated to grow from USD 24,389 million in 2025 and is projected to be ...

Medicare Part D, an optional component of Medicare, helps beneficiaries pay for generic and name-brand prescription drugs. A Low Income Subsidy ... especially for brand-name specialty oral anticancer ...

The most expensive drug category for nonfederal hospitals in 2024 were antineoplastic targeted agents, according to a study published in the American Journal of Health-System Pharmacy.  The report, ...

Therapeutic areas. Among the 1,100 new drugs approved by the NMPA from 2016 to 2024, 382 were anticancer drugs (35%), followed by endocrine and metabolic drugs with 128 products (12%), anti ...

Phase I, First-in-Human Study of FOR46 (FG-3246), an Immune-Modulating Antibody-Drug Conjugate Targeting CD46, in Patients With Metastatic Castration-Resistant Prostate Cancer N.K. and C.K. were ...

Despite significant advances in cancer diagnosis and treatment, tumor recurrence, metastasis, and drug resistance remain major clinical challenges. These ...

Just as species adapt over generations, our body's cells accumulate DNA changes throughout life. Most are harmless, yet a few ...